Optically Active Aromatic and Heteroaromatic R-Amino Acids
NMR δ 169.1, 155.6, 152.6, 146.9, 109.2, 106.5, 62.0, 61.3, 52.0,
J . Org. Chem., Vol. 67, No. 12, 2002 4359
(s, 3H), 1.24 (s, 9H); 13C NMR δ 169.7, 164.8, 156.1, 146.3,
14.4, 14.0, 13.5; [R]rt ) -73.6 (c ) 0.25 in CHCl3) (73% ee);
108.8, 102.9, 52.9, 52.5, 52.1, 32.6, 28.9; [R]rt ) -132.0 (c )
D
D
GC (Chiraldex G-TA, 70-140 °C (10 °C/min), 140-145 °C (1
°C/min) then 145 °C isotherm) tR ) 34.27 min (major enanti-
omer), tR ) 35.72 min (minor enantiomer); HRMS C12H17NO5
[M + Na]+ calcd 278.1004, found 278.1000.
1 in CHCl3) (95% ee); GC (Chiraldex B-PM, 70-110 °C (5 °C/
min), 110 °C isotherm (10 min), 110-160 (2 °C/min) then 160
°C isotherm: tR ) 41.00 min (major enantiomer), tR ) 41.32
min (minor enantiomer); HRMS C13H19NO5 [M + Na]+ calcd
292.1161, found 292.1165.
Ben zyloxyca r b on yla m in o(5-m et h ylfu r a n -2-yl)a cet ic
1
a cid eth yl ester 5d : H NMR δ 7.40-7.30 (m, 5H), 6.22 (d,
(5-Ben zylfu r an -2-yl)m eth oxycar bon ylam in oacetic acid
m eth yl ester 5k : 1H NMR δ 7.32-7.19 (m, 5H), 6.25 (d,
3J (H,H) ) 3.2 Hz, 1H), 5.91 (d, 3J (H,H) ) 3.0 Hz, 1H), 5.64
(bd, 3J (H,H) ) 7.5 Hz, 1H), 5.46 (d, 3J (H,H) ) 8.3 Hz, 1H),
3.93 (s, 2H), 3.75 (s, 3H), 3.69 (s, 3H); 13C NMR δ 169.5, 156.0,
155.3, 147.3, 137.5, 128.7, 128.5, 126.6, 109.4, 107.3, 52.9, 52.5,
3
3J (H,H) ) 2.6 Hz, 1H), 5.92-5.91 (m, 1H), 5.72 (bd, J (H,H)
) 8.1 Hz, 1H), 5.43 (d, 3J (H,H) ) 8.2 Hz, 1H), 5.12 (s, 2H),
4.29-4.14 (m, 2H), 2.25 (s, 3H), 1.25 (t, 3J (H,H) ) 7.1 Hz, 3H);
13C NMR δ 169.0, 155.4, 152.7, 146.7, 136.1, 128.5, 128.2,
128.1, 109.3, 106.6, 67.1, 62.1, 52.1, 14.0, 13.5; [R]rt ) -84.4
D
(c ) 1.0 in CHCl3) (79% ee); HPLC (Daciel Chiralcel OD,
hexane/2-propanol 97/3, 1 mL/min) tR ) 17.0 min (minor
52.0, 34.4; [R]rt ) -132.0 (c ) 1 in CHCl3) (95% ee); HPLC
D
(Daicel Chiralpak AS, hexane/2-propanol 95/5, 1 mL/min) tR
) 18.3 min (minor enantiomer), tR ) 25.7 min (major enanti-
omer); HRMS C16H17NO5 [M + Na]+ calcd 326.1004, found
326.1005.
enantiomer), tR ) 25.9 min (major enantiomer); HRMS C17H19
-
NO5 [M + Na]+ calcd 340.1161, found 340.1164.
Meth oxycar bon ylam in o(5-m eth ylfu r an -2-yl)acetic acid
eth yl ester 5e: 1H NMR δ 6.20 (d, 3J (H,H) ) 2.8 Hz, 1H),
5.90-5.89 (m, 1H), 5.68 (bd, 3J (H,H) ) 7.2 Hz, 1H), 5.40 (d,
3J (H,H) ) 8.3 Hz, 1H), 4.28-4.15 (m, 2H), 3.67 (s, 3H), 2.23
(s, 3H), 1.24 (t, 3J (H,H) ) 7.0 Hz, 3H); 13C NMR δ 169.1, 156.0,
Meth oxyca r bon yla m in o[5-(4-m eth oxyp h en yl)fu r a n -2-
1
yl]a cetic a cid m eth yl ester 5l: H NMR δ 7.53 (dt, J (H,H)
3
) 8.7 Hz, 2.5 Hz, 2H), 6.88 (d, J (H,H) ) 9.3 Hz, 2H), 6.44 (d,
3J (H,H) ) 3.4 Hz, 1H), 5.40 (d, 3J (H,H) ) 3.0 Hz, 1H), 5.88
(bd, 3J (H,H) ) 7.7 Hz, 1H), 5.55 (d, 3J (H,H) ) 8.1 Hz, 1H),
3.80 (s, 3H), 3.76 (s, 3H), 3.69 (s, 3H); 13C NMR δ 169.4, 159.2,
156.0, 154.3, 147.2, 125.2, 123.2, 114.0, 110.6, 104.1, 55.2, 52.9,
152.6, 146.8, 109.2, 106.5, 62.0, 52.4, 52.1, 14.0, 13.5; [R]rt
)
D
-103.4 (c ) 1.0 in CHCl3) (81% ee); GC (Chiraldex B-PM, 70
°C (isotherm 5 min), 70-150 °C (2 °C/min) then 150 °C
isotherm) tR ) 45.44 min (minor enantiomer), tR ) 45.72 min
(major enantiomer); HRMS C11H15NO5 [M + Na]+ calcd
264.0848, found 264.0849.
52.4, 52.0; [R]rt ) -108 (c ) 1.0 in CHCl3) (74% ee); HPLC
D
(Daicel Chiralpak AS, hexane/2-propanol 95/5, 1 mL/min) tR
) 29.3 min (minor enantiomer), tR ) 39.1 min (major enanti-
omer); HRMS C16H17NO6 [M + Na]+ calcd 342.0954, found
342.0955.
Meth oxycar bon ylam in o(5-m eth ylfu r an -2-yl)acetic acid
ben zyl ester 5f: 1H NMR δ 7.34-7.25 (m, 5H), 6.20 (d,
3
3J (H,H) ) 3.2 Hz, 1H), 5.91-5.90 (m, 1H), 5.64 (bd, J (H,H)
Met h oxyca r b on yla m in o(5-m et h oxyfu r a n -2-yl)a cet ic
3
3
) 8.3 Hz, 1H), 5.49 (d, J (H,H) ) 8.2 Hz, 1H), 5.25-5.17 (m,
a cid m eth yl ester 5m : 1H NMR δ 6.21 (d, J (H,H) ) 3.1 Hz,
2H), 3.69 (s, 3H), 2.23 (s, 3H); 13C NMR δ 169.0, 156.1, 152.7,
146.6, 135.2, 128.5, 128.3, 127.9, 109.5, 106.6, 67.5, 52.5, 52.2,
13.5; [R]rtD ) -45.2 (c ) 0.25 in CHCl3) (55% ee); HPLC (Daicel
Chiralpak AS, hexane/2-propanol 97/3, 1 mL/min) tR ) 17.6
min (minor enantiomer), tR ) 27.8 min (major enantiomer);
HRMS C16H17NO5 [M + Na]+ calcd 326.1004, found 326.1003.
Meth oxycar bon ylam in o(5-m eth ylfu r an -2-yl)acetic acid
isop r op yl ester 5g: 1H NMR δ 6.19 (d, 3J (H,H) ) 3.2 Hz,
1H), 5.69 (bd, 3J (H,H) ) 8.2 Hz, 1H), 5.34 (d, 3J (H,H) ) 8.2
3
Hz, 1H), 5.07 (d, J (H,H) ) 3.44 Hz, 1H), 3.79 (s, 3H), 3.74 (s,
3H), 3.66 (s, 3H); 13C NMR δ 169.3, 161.5, 156.0, 138.3, 110.2,
80.2, 57.7, 52.9, 52.4, 51.9; [R]rtD ) -114 (c ) 1 in CHCl3) (96%
ee); HPLC (Daicel Chiralpak AS, hexane/2-propanol 90/10, 1
mL/min) tR ) 23.9 min (minor enantiomer), tR ) 28.7 min
(major enantiomer); HRMS C10H13NO6 [M + Na]+ calcd
266.0641, found 266.0633.
3
1H), 5.91-5.89 (m, 1H), 5.64 (bd, J (H,H) ) 7.0 Hz, 1H), 5.37
Meth oxycar bon ylam in o(4-m eth ylfu r an -2-yl)acetic acid
(d, 3J (H,H) ) 8.3 Hz, 1H), 5.07 (sep, 3J (H,H) ) 6.3 Hz, 1H),
m eth yl ester 5n : H NMR δ 7.24 (s, 1H), 6.20 (s, 1H) 5.78
1
3
3.69 (s, 3H), 2.24 (s, 3H), 1.26 (d, J (H,H) ) 6.3 Hz, 3H), 1.18
(bd, 3J (H,H) ) 7.4 Hz, 1H), 5.48 (d, 3J (H,H) ) 8.3 Hz, 1H),
3.73 (s, 3H), 3.67 (s, 3H), 2.08 (s, 3H); 13C NMR δ 169.6, 156.1,
143.8, 141.8, 118.4, 113.3, 52.9, 52.4, 49.8, 9.5; [R]rtD ) -124.0
(c ) 1.0 in CHCl3) (72% ee); HPLC (Daicel Chiralpak AD,
hexane/2-propanol 95/5, 1 mL/min) tR ) 12.4 min (major
(d, 3J (H,H) ) 6.2 Hz, 3H); 13C NMR δ 168.6, 156.1, 152.5,
147.0, 109.1, 106.5, 69.8, 52.4, 52.2, 21.6, 21.4, 13.5; [R]rt
)
D
-70.4 (c ) 0.5 in CHCl3) (79% ee); GC (Chiraldex B-PM, 70-
140 °C (10 °C/min), 140-160 °C (2 °C/min) then 160 °C
isotherm) tR ) 16.11 min (minor enantiomer), tR ) 16.35 min
(major enantiomer); HRMS C12H17NO5 [M + Na]+ calcd
278.1004, found 278.1006.
enantiomer); tR ) 14.9 min (minor enantiomer); HRMS C11H15
-
NO5 [M + Na]+ calcd 250.0691, found 250.0690.
(4,5-Dim et h ylfu r a n -2-yl)m et h oxyca r b on yla m in oa ce-
1
Meth oxycar bon ylam in o(5-m eth ylfu r an -2-yl)acetic acid
tic a cid m eth yl ester 5o: H NMR δ 6.11 (s, 1H), 5.68 (bd,
1
3
m eth yl ester 5h : H NMR δ 6.21 (d, J (H,H) ) 3.2 Hz, 1H),
5.91-5.90 (m, 1H), 5.69 (bd, 3J (H,H) ) 6.9 Hz, 1H), 5.42 (d,
3J (H,H) ) 8.2 Hz, 1H), 3.75 (s, 3H), 3.68 (s, 3H), 2.24 (s, 3H);
13C NMR δ 169.6, 156.0, 152.7, 146.6, 109.4, 106.5, 52.9, 52.4,
3J (H,H) ) 7.2 Hz, 1H), 5.37 (d, 3J (H,H) ) 8.2 Hz, 1H), 3.75 (s,
3H), 3.67 (s, 3H), 2.14 (s, 3H), 1.88 (s, 3H); 13C NMR δ 169.6,
156.0, 148.0, 145.3, 114.9, 111.7, 52.9, 52.4, 51.9, 11.2, 9.9;
[R]rtD ) -130.0 (c ) 1 in CHCl3) (84% ee); GC (Chiraldex B-PM,
70-110 °C (5 °C/min), 110-160 °C (2 °C/min) then 160 °C
isotherm) tR ) 40.73 min (minor enantiomer), tR ) 40.92 min
(major enantiomer); HRMS C11H15NO5 [M + Na]+ calcd
264.0848, found 264.0845.
51.9, 13.4; [R]rt ) -123.0 (c ) 1 in CHCl3) (87% ee); HPLC
D
(Daicel Chiralpak AS, hexane/2-propanol 97/3, 1 mL/min) tR
) 19.2 min (minor enantiomer), tR ) 25.2 min (major enanti-
omer); HRMS C10H13NO5 [M + Na]+ calcd 250.0691, found
250.0692.
Meth oxyca r bon yla m in o(5-m eth oxyth iop h en -2-yl)a ce-
1
3
(5-Eth ylfu r a n -2-yl)m eth oxyca r bon yla m in oa cetic a cid
tic a cid m eth yl ester 5p : H NMR δ 6.65 (d, J (H,H) ) 3.7
3 3
1
3
m eth yl ester 5i: H NMR δ 6.22 (d, J (H,H) ) 2.4 Hz, 1H),
5.92-5.91 (m, 1H), 5.68 (bd, 3J (H,H) ) 6.9 Hz, 1H), 5.43 (d,
3J (H,H) ) 8.6 Hz, 1H), 3.75 (s, 3H), 3.68 (s, 3H), 2.58 (q,
3J (H,H) ) 7.5 Hz, 2H), 1.18 (d, 3J (H,H) ) 7.4 Hz, 3H); 13C
NMR δ 169.6, 158.4, 156.0, 146.4, 109.1, 104.9, 52.9, 52.4, 52.0,
Hz, 1H), 5.07 (d, J (H,H) ) 4.3 Hz, 1H), 5.71 (bd, J (H,H) )
3
7.1 Hz, 1H), 5.43 (d, J (H,H) ) 7.7 Hz, 1H), 3.83 (s, 3H), 3.76
(s, 3H), 3.67 (s, 3H); 13C NMR δ 170.5, 166.5, 155.8, 124.1,
124.0, 103.2, 60.1, 53.9, 52.9, 52.4; [R]rt ) -131 (c ) 1 in
D
CHCl3) (94% ee); HPLC (Daicel Chiralpak AS, hexane/2-
propanol 90/10, 1 mL/min) tR ) 21.8 min (minor enantiomer),
tR ) 43.1 min (major enantiomer); HRMS C10H13NO5S [M +
Na]+ calcd 282.0412, found 282.0416.
[5-(4-Dim et h yla m in op h en yl)t h iop h en -2-yl]m et h oxy-
ca r bon yla m in oa cetic a cid m eth yl ester 5q: 1H NMR δ 7.42
(d, 3J (H,H) ) 8.5 Hz, 2H), 6.99-6.96 (m, 2H), 6.70 (d, 3J (H,H)
) 8.8 Hz, 2H), 5.76 (bd, 3J (H,H) ) 7.6 Hz, 1H), 5.61 (d, 3J (H,H)
) 7.8 Hz, 1H), 3.80 (s, 3H), 3.71 (s, 3H), 2.98 (s, 6H); 13C NMR
δ 170.6, 155.9, 150.0, 146.0, 135.3, 127.1, 126.7, 122.1, 120.4,
21.2, 11.8; [R]rt ) -131 (c ) 0.5 in CHCl3) (88% ee); HPLC
D
(Daicel Chiralpak AS, hexane/2-propanol 95/5, 1 mL/min) tR
) 12.5 min (minor enantiomer), tR ) 15.2 min (major enanti-
omer); HRMS C11H15NO5 [M + Na]+ calcd 264.0848, found
264.0847.
(5-ter t-Bu t ylfu r a n -2-yl)m et h oxyca r b on yla m in oa ce-
1
3
tic a cid m eth yl ester 5j: H NMR δ 6.21 (d, J (H,H) ) 2.8
3
3
Hz, 1H), 5.91 (d, J (H,H) ) 5.9 Hz, 1H), 5.59 (bd, J (H,H) )
6.5 Hz, 1H), 5.46 (d, J (H,H) ) 7.3 Hz, 1H), 3.77 (s, 3H), 3.71
3